fda warning peptides bpc 157 not approved 2024 2025 to discuss easing restrictions on despite safety concerns | US healthcare fda warning bpc-157 unapproved peptide
Description
Mino, a platform built for clinicians and med spas to access peptides, purchased a South Carolina factory that already held compounding licenses across multiple states
The current FDA position on these peptides certainly puts a greater burden on consumers
AOD-9604 avoids these issues while still promoting fat metabolism and tissue repair
No one really knows for sure what causes it, and there isnt any medication or treatment that can clear it up quickly
